tiprankstipranks
3 Best Stocks to Buy Now, 3/10/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 3/10/2025, According to Top Analysts
14d ago
Arcturus Therapeutics’ Earnings Call: Mixed Outlook with Strategic Wins
Premium
Company Announcements
Arcturus Therapeutics’ Earnings Call: Mixed Outlook with Strategic Wins
16d ago
Arcturus Therapeutics price target lowered to $60 from $63 at H.C. Wainwright
Premium
The Fly
Arcturus Therapeutics price target lowered to $60 from $63 at H.C. Wainwright
17d ago
Arcturus Therapeutics price target raised to $48 from $41 at BTIG
PremiumThe FlyArcturus Therapeutics price target raised to $48 from $41 at BTIG
1M ago
Arcturus Therapeutics: Buy Rating Affirmed on EU Approval and Promising Clinical Data for Kostaive Vaccine
Premium
Ratings
Arcturus Therapeutics: Buy Rating Affirmed on EU Approval and Promising Clinical Data for Kostaive Vaccine
1M ago
Arcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
Premium
The Fly
Arcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
1M ago
Arcturus initiates dosing in Phase 2 studies for CF and OTC deficiency
PremiumThe FlyArcturus initiates dosing in Phase 2 studies for CF and OTC deficiency
3M ago
Arcturus Therapeutics receives FDA clearance to begin H5N1 vaccine trial
Premium
The Fly
Arcturus Therapeutics receives FDA clearance to begin H5N1 vaccine trial
4M ago
Arcturus Therapeutics (ARCT): Impressive Pipeline and Potentially Promising Future
Premium
Market News
Arcturus Therapeutics (ARCT): Impressive Pipeline and Potentially Promising Future
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100